Microarray based gene expression profiling studies have led to the identification of hundreds of genes differentially expressed across diverse sample sets which has resulted in the characterization of several biomarkers and genes of interest. But the bigger promise of providing an insight into underlying biological phenomena continues to be challenging. Several methods have been introduced for synthesizing 'expression signatures' in terms of associated molecular phenomena/ pathways over the last decade. Here, we introduce a new approach -Sum-based Meta-analytical Enrichment (SME) -which is a combined enrichment and meta-analytical approach, to infer on the association of gene sets with particular phenotypes. SME allows enrichment to be performed across datasets, which to our knowledge was not earlier possible. As a proof of concept study, we apply this technique to datasets from Oncomine, a publicly available cancer microarray database.
Background
Microarray based gene expression profiling studies have led to the identification of hundreds of genes differentially expressed across diverse sample sets which has resulted in the characterization of several biomarkers and genes of interest. But the bigger promise of providing an insight into underlying biological phenomena continues to be challenging. Several methods have been introduced for synthesizing 'expression signatures' in terms of associated molecular phenomena/ pathways over the last decade. Here, we introduce a new approach -Sum-based Meta-analytical Enrichment (SME) -which is a combined enrichment and meta-analytical approach, to infer on the association of gene sets with particular phenotypes. SME allows enrichment to be performed across datasets, which to our knowledge was not earlier possible. As a proof of concept study, we apply this technique to datasets from Oncomine, a publicly available cancer microarray database.
Results
We listed genes that are significantly up-/down-regulated (p-value ≤ 10 -4 ) in various cancers types in Oncomine. These genes were assigned to biological processes using GO annotations. The SME algorithm was carried out to identify a list of GO processes most deregulated in 4 major cancer types. As a preliminary assessment of SME, we examined whether these predicted association were already documented. Conclusions SME method identified several known processes for the 4 cancer types and identified several novel processes which are biologically plausible. SME provides an intuitive yet objective 'process-centric' interpretation of the 'gene-centric' output of individual microarray comparison studies.
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